Point of care C-reactive protein testing may be useful in guiding ...
Dec 6, 2024 · 1. C-reactive protein (CRP)-point-of-care tests can be used to guide antibiotic prescribing in primary care for patients with acute exacerbations of COPD with no reduction in …
Adjuvant durvalumab therapy improves survival in limited-stage …
Nov 21, 2024 · 1. In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival compared to placebo in patients with limited …
Iterum’s Sulopenem receives FDA approval for treatment of …
Nov 11, 2024 · Company History: Founded in 2015, Iterum therapeutics is an Irish based pharmaceutical company focused on developing anti-infectives to solve the multi-drug …
Plasma progranulin levels are correlated with left ventricular …
Nov 15, 2024 · 1. In this prospective cohort of patients with acute myocardial infarction (AMI), plasma progranulin levels increased acutely after the AMI. 2. The increase in plasma …
The Child-Pugh score: Prognosis in chronic liver disease and …
Dec 3, 2023 · 1. The Child-Pugh score consists of five clinical features and is used to assess the prognosis of chronic liver disease and cirrhosis. 2. The Child-Pugh score was originally …
Early oral anticoagulation is non-inferior to delayed treatment in ...
Dec 11, 2024 · 1. Early DOAC therapy within 4 days was non-inferior to delayed therapy for the composite outcome of recurrent ischemic or unclassified stroke, symptomatic intracranial …
The Lee index: Risk of perioperative cardiac events [Classics Series ...
Sep 27, 2014 · 1. The Lee index is a prospectively validated model that predicts the risk of a cardiac event in patients undergoing noncardiac surgery. 2. The six independent predictors …
Influenza vaccination may reduce secondary infection spread …
Dec 1, 2024 · 1. Influenza vaccination was associated with a reduced risk of secondary influenza infections among household contacts, with an estimated effectiveness of 21%. Evidence …
RAMOSE Phase II trial finds promising results for osimertinib and ...
Dec 10, 2024 · 1. Treatment of patients with tyrosine kinase inhibitor (TKI)-naïve epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) with osimertinib …
MRI-informed biopsy recommendation reduces overdiagnosis in …
Oct 9, 2024 · 1. In this randomized controlled trial of men aged 50 to 60, forgoing prostate biopsies in those with elevated PSA but negative MRI reduced the diagnosis of clinically …